Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
15323 studies found for:    Studies With Results
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed
Has Results
A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Herceptin
2 Active, not recruiting
Has Results
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
Condition: Herpes Zoster
Intervention: Biological: Zoster Vaccine, Live
3 Completed
Has Results
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Condition: Overactive Bladder
Interventions: Drug: trospium chloride;   Drug: placebo
4 Completed
Has Results
Anesthesia and Lymphocytes Apoptosis
Condition: Anesthesia
Interventions: Drug: Sevoflurane;   Drug: Propofol;   Drug: combine of sevoflurane and propofol
5 Completed
Has Results
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms
Condition: Breast Neoplasms
Interventions: Drug: Letrozole / Temsirolimus (CCI-779);   Drug: Letrozole
6 Completed
Has Results
Cooling Pillow for Atopic Dermatitis
Conditions: Atopic Dermatitis;   Eczema
Interventions: Other: Current standard eczema treatment and standard pillow at night;   Other: Chillow cooling pillow
7 Completed
Has Results
Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Sleep Intervention;   Drug: Melatonin
8 Completed
Has Results
Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs
Condition: Focal Epilepsy
Interventions: Drug: Levetiracetam;   Drug: Carbamazepine;   Drug: Lamotrigine
9 Terminated
Has Results
Chemoradiation in Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy;   Procedure: Resection of tumor
10 Completed
Has Results
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
Condition: Rhinitis, Allergic, Perennial and Seasonal
Interventions: Drug: Levocabastine;   Drug: Placebo
11 Completed
Has Results
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Condition: Focal Dystonia
Interventions: Drug: Acetyl-Hexapeptide Topical Treatment;   Drug: placebo
12 Completed
Has Results
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
Condition: Dermatitis, Contact
Intervention: Biological: T.R.U.E. Test
13 Terminated
Has Results
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Conditions: Transplantation, Kidney;   End-Stage Renal Disease
Interventions: Drug: Belatacept;   Drug: Sirolimus;   Drug: Anti-thymocyte globulin;   Drug: methylprednisolone
14 Completed
Has Results
Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
Condition: Myelofibrosis
Intervention: Drug: Ruxolitinib
15 Completed
Has Results
Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)
Condition: Primary Hypercholesterolemia
Interventions: Drug: Ezetimibe;   Drug: Atorvastatin;   Drug: Rosuvastatin
16 Completed
Has Results
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
Conditions: Cardiovascular Disorder;   Diabetes Mellitus
Interventions: Drug: ezetimibe (+) simvastatin;   Drug: simvastatin 40 mg or atorvastatin 20 mg;   Drug: Rosuvastatin;   Drug: atorvastatin 10 mg or simvastatin 20 mg
17 Completed
Has Results
Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)
Condition: Chemotherapy-Induced Nausea and Vomiting (CINV)
Interventions: Drug: Fosaprepitant 150 mg;   Drug: Aprepitant 165 mg;   Drug: Aprepitant 250 mg;   Drug: Dexamethasone (12-8-16-16 mg);   Drug: Dexamethasone (12-8-8-16 mg);   Drug: Ondansetron;   Drug: MK0999
18 Completed
Has Results
Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED
Condition: Erectile Dysfunction
Interventions: Drug: placebo;   Drug: avanafil
19 Completed
Has Results
A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg;   Drug: Canagliflozin 300 mg;   Drug: Antihyperglycemic agent(s);   Drug: Placebo
20 Completed
Has Results
Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting
Condition: Stroke
Interventions: Drug: Ranitidine;   Drug: Placebo;   Other: Advanced notification;   Other: No advanced notification

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years